Table 2 Percentages of nuclei with different numbers of signals from neoplastic cells

From: Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma

No. case

Chromosome 1

Chromosome 2

Chromosome 6

Chromosome 10

Chromosome 17

 

Percentage of nuclei

Percentage of nuclei

Percentage of nuclei

Percentage of nuclei

Percentage of nuclei

 

1 sign.

2 sign.

≥3 sign.

1 sign.

2 sign.

≥3 sign.

1 sign.

2 sign.

≥3 sign.

1 sign.

2 sign.

≥3 sign.

1 sign.

2 sign.

≥3 sign.

Chromophobe RCC with sarcomatoid transformation

1 Epithelial

18

75

7

14

83

3

15

79

6

11

79

10

14

69

17

1 Sarcomatoid

12

38

50

19

21

60

31

51

18

17

40

43

23

42

35

2 Epithelial

16

75

9

24

64

12

14

66

20

22

70

8

22

68

10

2 Sarcomatoid

20

41

39

15

44

41

12

30

58

12

35

53

5

39

56

3 Epithelial

76

20

4

78

17

5

82

14

4

15

82

3

23

60

17

3 Sarcomatoid

56

34

10

63

27

10

78

16

6

12

40

48

24

40

36

4 Epithelial

12

20

68

17

30

53

12

22

66

20

36

44

21

47

32

4 Sarcomatoid

10

25

65

9

26

65

11

20

69

12

33

55

20

22

58

5 Epithelial

10

44

46

12

33

55

9

55

36

7

33

60

10

44

46

5 Sarcomatoid

12

55

33

8

33

59

12

34

54

18

45

37

5

23

72

6 Epithelial

86

10

4

12

80

8

43

55

2

86

10

4

11

88

1

6 Sarcomatoid

18

45

37

15

45

40

18

45

37

13

44

43

6

44

50

Chromophobe RCC with distant metastases

7 Primary

84

12

4

86

10

4

80

10

10

80

17

3

76

21

3

7 Pulmonary mts

82

12

6

82

10

8

78

19

3

79

12

9

86

12

2

8 Primary

89

8

3

80

13

7

80

15

5

82

13

5

65

30

5

8 Pancreatic mts

71

20

9

72

22

6

68

18

14

75

15

10

73

17

10

9 Primary

12

78

10

12

80

8

15

80

5

11

82

7

19

78

3

9 Lymph-nodal mts

13

81

6

16

75

9

21

73

6

12

80

8

15

83

2